Tissue Factor Pathway Inhibitor Antagonist [EPC] - N0000194160

Pharmacologic Code	N0000194160
Pharmacologic Name	Tissue Factor Pathway Inhibitor Antagonist
Pharmacologic Uses	tissue factor pathway inhibitor (TFPI) antagonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Tissue Factor Pathway Inhibitor Antagonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0169-2080	Alhemo	Non-Proprietary Name: Concizumab	Injection, Solution	Subcutaneous	Novo Nordisk	ACTIVE
	0169-2081	Alhemo	Non-Proprietary Name: Concizumab	Injection, Solution	Subcutaneous	Novo Nordisk	ACTIVE
	0169-2084	Alhemo	Non-Proprietary Name: Concizumab	Injection, Solution	Subcutaneous	Novo Nordisk	ACTIVE